Consumer Driven Health Care

The consolidated whistleblower lawsuit accuses the pharmacy chain of helping to fuel the opioid crisis, by systematically pressuring its pharmacists to fill prescriptions, including controlled substances, without taking time to confirm their validity.

When asked about a variety of health care proposals, including those put forth by Republican and Democratic lawmakers, about 6 in 10 said boosting price transparency rules to ensure that health care prices are available to patients should be a top priority.

The ERISA Industry Committee sues to stop new Biden administration mental health regulations issued in 2024, saying they are “arbitrary and capricious” and employers cannot certify compliance “due to vague, undefined terms."

Various pieces of health care transparency legislation have identified areas requiring employers to meet their fiduciary responsibilities, such as designing an evaluation process for selecting vendors to deploy their health and welfare benefits strategy.

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, including Pfizer, Novo Nordisk and GlaxoSmithKline.

A new research report from Colliers finds that the role of retail pharmacies has changed over time, moving far beyond roles as medication dispensaries.